Results 31 to 40 of about 8,530 (198)

HPV types and cofactors causing cervical cancer in Peru. [PDF]

open access: yes, 2001
We conducted a hospital-based case-control study in Peru of 198 women with histologically confirmed cervical cancer (173 squamous cell carcinomas and 25 cases of adenocarcinoma/adenosquamous carcinoma) and 196 control women.
Muñoz, N   +23 more
core   +1 more source

Gankyrin is frequently overexpressed in cervical high grade disease and is associated with cervical carcinogenesis and metastasis. [PDF]

open access: yesPLoS ONE, 2014
Our previous studies have showed that Gankyrin expression is correlated with a malignant phenotype in endometrial carcinoma. Here, we investigated the possible role of Gankyrin in cervical disease. The increasing protein level of Gankyrin was observed in
Yuan Liu   +9 more
doaj   +1 more source

Metachronous Occurrence of Anal Canal and Cervical Carcinoma: A Rare Case Report

open access: yesIndian Journal of Colo-Rectal Surgery, 2022
The occurrence of a second primary cancer in a cancer survivor is well documented. It may be synchronous or metachronous. We present a rare case of a 70-year-old woman who presented with bleeding per rectum and was diagnosed with basosquamous anal ...
Kafil Akhtar   +3 more
doaj   +1 more source

Cervical cancer screening programs in Latin America and the Caribbean. [PDF]

open access: yes, 2008
Latin America and the Caribbean (LAC) have a significant burden of cervical cancer. Prophylactic human papillomavirus (HPV) vaccines are an opportunity for primary prevention and new screening methods, such as new HPV DNA testing, are promising ...
Gamboa, Oscar A   +9 more
core   +1 more source

Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. [PDF]

open access: yes, 2008
Human papillomavirus (HPV) infection causes cervical cancer and premalignant dysplasia. Type-specific HPV prevalence data provide a basis for assessing the impact of HPV vaccination programmes on cervical cytology.
Bailey, A   +23 more
core   +1 more source

Meta-analysis about correlation between the human Papillomavirus infection and the incidence of cervical intraepithelial Neoplasia

open access: yesJournal of the Pakistan Medical Association
Objective: To determine the correlations between human papillomavirus infection and the incidence of cervical intraepithelial neoplasia. Method:This study was conducted in the Affiliated Hospital of Zunyi Medical University, Zunyi, China in January 2024.
Mingyang Wang   +2 more
doaj   +1 more source

Etiology and pathogenesis of cervical intraepithelial neoplasia (review of foreign literature)

open access: yesМедицинский совет, 2015
Cervical intraepithelial neoplasia (CIN) is atypical transformation of squamos epithelium without stromal invasion predictive of cervical cancer. According to the World Health Organization (2014), there is mild cervical epithelial neoplasia (CIN I; mild
S. A. Levakov   +2 more
doaj   +1 more source

Health Care Policy Implementation Trial of Primary Human Papillomavirus–Based Cervical Screening in Denmark

open access: yesInternational Journal of Cancer, EarlyView.
Uncertainty has persisted over whether human papillomavirus (HPV) testing outperforms high‐quality cytology in real‐world cervical cancer screening programs. To address this, Denmark launched a nationwide trial in 2021, implementing an HPV‐based screening strategy using specialized algorithms integrated with molecular and cytology triage to optimize ...
Jesper Bonde   +12 more
wiley   +1 more source

Determining the relationship between serum acute phase reactants and cervical premalignant lesions: a cohort study

open access: yesSão Paulo Medical Journal, 2022
BACKGROUND: Acute phase reactants play a role in the progression and prognosis of many malignant and premalignant tumors. This study investigated the diagnostic value of certain reactants as markers for cervical premalignant lesions. OBJECTIVES: Despite
Yeliz Acar Sabır   +2 more
doaj   +1 more source

Clinical Validation of Four Point‐of‐Care High‐Risk HPV Assays, Including Two Reduced‐Valency Assays, for Cervical Cancer Screening in Low‐Resource Settings

open access: yesInternational Journal of Cancer, EarlyView.
High‐risk human papillomavirus (hrHPV) testing improves cervical cancer screening by facilitating earlier detection and prevention. In low‐resource settings, however, cost and increased referrals limit its use. At the same time, many new and more affordable assays lack validation.
Neerja Bhatla   +28 more
wiley   +1 more source

Home - About - Disclaimer - Privacy